A detailed history of Fortis Group Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 120 shares of EW stock, worth $9,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 120 -0.0%
Holding current value
$9,045
Previous $11.1 Million 28.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$72.54 - $95.56 $8,704 - $11,467
-120 Reduced 50.0%
120 $11.5 Million
Q4 2023

Mar 04, 2024

BUY
$61.71 - $77.76 $7,405 - $9,331
120 Added 100.0%
240 $18.3 Million
Q3 2023

Dec 01, 2023

BUY
$69.28 - $93.38 $8,313 - $11,205
120 New
120 $8.31 Million
Q1 2023

May 26, 2023

SELL
$74.26 - $84.51 $8,911 - $10,141
-120 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$67.19 - $87.44 $8,062 - $10,492
120 New
120 $9,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.